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Abstract
Purpose Follow-up infarct volume (FIV) is moderately associated with functional outcome. We hypothesized that account-
ing for infarct location would strengthen the association of FIV with functional outcome.
Methods We included 252 patients from the HERMES collaboration with follow-up diffusion weighted imaging. Patients 
received endovascular treatment combined with best medical management (n = 52%) versus best medical management alone 
(n = 48%). FIV was quantified in low, moderate and high modified Rankin Scale (mRS)-relevant regions. We used binary 
logistic regression to study the relation between the total, high, moderate or low mRS-relevant FIVs and favorable outcome 
(mRS < 2) after 90 days. The strength of association was evaluated using the c-statistic.
Results Small lesions only occupied high mRS-relevant brain regions. Lesions additionally occupied lower mRS-relevant 
brain regions if FIV expanded. Higher FIV was associated with a higher risk of unfavorable outcome, as were volumes of 
tissue with low, moderate and high mRS relevance. In multivariable modeling, only the volume of high mRS-relevant infarct 
was significantly associated with favorable outcome. The c-statistic was highest (0.76) for the models that included high 
mRS-relevant FIV or the combination of high, moderate and low mRS-relevant FIV but was not significantly different from 
the model that included only total FIV (0.75).
Conclusion This study confirms the association of FIV and unfavorable functional outcome but showed no strengthened 
association if lesion location was taken into account.
Keywords Acute ischemic stroke · Follow-up infarct location · Diffusion weighted imaging · Functional outcome
Introduction 
Despite advances in treatment of acute ischemic stroke 
(AIS), many patients do not return to functional independ-
ence. Insight into the course of disease obtained by the pre-
diction of functional outcome might help patient specific 
rehabilitation. For example, the patient and family could 
be informed on realistic expectations about recovery, and 
rehabilitation therapy could be focused specifically on the 
patient’s needs.
Follow-up infarct volume (FIV) is associated with func-
tional outcome after AIS and has been suggested as a prog-
nostic marker. However, FIV is only moderately associated 
with outcome: only 12% of functional outcome is explained 
by FIV [1]. Moreover, the association between the volume of 
infarcted tissue and functional outcome varies among lesion 
locations[2–4].
Infarcts that are located in highly modified Rankin Scale 
(mRS)-relevant regions negatively affect functional out-
come, even when the lesion is small[2–5]. Ernst et al.[2] 
and Sheth et al. [6] showed that the association between 
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lesion volume and functional outcome, measured by mRS at 
90 days, is stronger if lesion location is taken into account. 
In the study of Ernst et al., an increase in lesion volume in 
high mRS-relevant areas was associated with a higher risk 
of unfavorable outcome. In their study, lesion volume was 
quantified on 3 to 9 days follow-up (FU) non-contrast com-
puted tomography (NCCT) images.
Diffusion weighted imaging (DWI) is the preferred 
modality for assessing infarcted tissue due to its high sensi-
tivity, which reaches near 100% sensitivity within 6 h after 
stroke onset[7, 8]. We therefore aimed to study whether the 
association between FIV as depicted on FU DWI and func-
tional outcome according to the mRS at 90 days is strength-
ened when lesion location is taken into account for patients 
with an anterior large vessel occlusion.
Materials and methods
Patient population
We included patients from the HERMES collaboration with 
available FU DWI. The HERMES collaboration is a pro-
spective meta-analysis of seven clinical randomized con-
trolled trials (RCTs) that assessed the treatment efficacy of 
the combination of endovascular treatment (EVT) and best 
medical management including intravenous alteplase versus 
best medical management alone for patients with an occlu-
sion within the proximal anterior circulation (ICA, M1 and 
M2 occlusions)[9]. In case patients were randomized for 
additional endovascular treatment, intravenous thrombolysis 
was administered within 4.5 h if eligible. Most trials allowed 
randomization for EVT within 6 h. The REVASCAT trial 
and the ESCAPE trial allowed randomization within 8 and 
12 h respectively. Patients were excluded in case of poor 
FU DWI quality. Poor image quality scans included motion 
artefacts, noise or incomplete field of view. According to the 
trial protocols, if follow-up DWI was acquired, it was done 
at 24 h after treatment [10–14].
Each RCT in the HERMES collaboration was approved 
by the relevant national or local medical ethical commit-
tee. All medical images and reports were anonymized, and 
informed consent was obtained for each patient according 
to each trial protocol. Patients included in these trials con-
sented for participation on the individual trials as well as 
additional research with the data.
Lesion segmentation and regions
For segmentation, an initial coarse delineation was obtained 
by labeling all voxels as infarct positive that differed in 
intensity by ≥ 20% compared to the mirrored ROI at the 
contralateral side on trace DWI. Then, a subsequent manual 
adjustment was performed if needed by one of three expert 
neuroradiologists (WHvZ, LFMB or CM). Lesion segmen-
tations also included areas with parenchymal hemorrhage 
within and adjacent to the infarct. In this study, hemor-
rhage was recognized on DWI as hypointense regions. If 
the patients received decompressive hemicraniectomy and 
no pre-surgical scan was available, only lesions within the 
theoretical boundary of the skull were included within the 
segmentation.
Each brain was divided into 66 anatomical regions using 
three different atlases. We used the Laboratory of Neuro 
Imaging Probabilistic Brain Atlas [15], which includes 56 
mostly cortical regions. These regions were extended with 
internal capsule, corona radiata, thalamus, corpus callosum 
and middle cerebral peduncles, which are part of the John 
Hopkins University International Consortium DTI-based 
white matter atlases [16] and Harvard–Oxford cortical and 
subcortical atlases [17–20]. The atlases were aligned to 
each DWI scan by affine and additional B-spline registration 
with the use of the statistical parametric mapping 8 toolbox 
(http:// www. fil. ion. ucl. ac. uk/ spm/). The regions were clas-
sified as high, moderate and low relevance for mRS, similar 
as presented by Ernst et al.[2] and according to a previously 
presented strength of association by Cheng et al. [3] (see 
Fig. 1). A voxel-based lesion mapping approach was used 
in which the impact of a brain region on functional outcome 
was represented by the Z-score acquired through a Brunner 
and Munzel Rank order test. Corresponding to these regions, 
total FIV was divided into sub-volumes categorized as being 
low, moderate and high mRS relevant.
Statistical analysis
Medians and interquartile ranges (IQR) are reported for all 
continuous variables. Frequencies (n) and percentages (%) 
are reported for all categorical and dichotomous variables. 
Odds ratios are presented per 10 mL of FIV with 95% confi-
dence interval. We tested for a significance level of p < 0.05.
Primary outcome was a favorable functional outcome 
according to the modified Rankin Scale (mRS), defined as 
mRS ≤ 2, at 90 days after stroke onset. For the primary out-
come, we performed unadjusted univariable and multivari-
able logistic regression analyses. The independent variables 
for the univariable models were total FIV and high, moder-
ate and low mRS-relevant FIV in milliliter. The independent 
variables for the multivariable model were high, moderate 
and low mRS-relevant FIV in milliliter. For each analysis, 
we performed an additional adjusted multivariable regres-
sion analysis in which we adjusted for age, sex, diabetes 
mellitus, atrial fibrillation, previous stroke or pre-stroke 
mRS > 0, treatment allocation, occlusion site, time from 
stroke onset to treatment and the collateral score.
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Secondary outcome was shift (on the mRS) towards bet-
ter functional outcome at 90 days, for which we performed 
ordinal logistic regression. We performed univariable and 
multivariable regression analysis as per the models for the 
primary outcome.
To study the quality of the statistical models, we com-
puted the c-statistic and the Akaike information criterion 
(AIC). For logistic regression, the c-statistic is the area 
under the curve (AUC) of the receiver operating charac-
teristic (ROC). An ROC graphically represents the ability 
of a binary classifier to predict the correct diagnosis as its 
discrimination threshold varies. The AUC represents the 
probability of the classifier to correctly predict the outcome. 
For ordinal outcomes, a single ROC no longer exists. In 
this case, the c-statistic can be computed from the cumula-
tive ROCs [21]. We used DeLong’s test [21] to compare the 
different c-statistics. The AIC gives a measure of the relative 
quality of fit of the models: it tests how well a model fits the 
sampled data compared to the other models that were fitted 
on the same data.
Results
Within the HERMES collaboration 307 patients had avail-
able 24-h FU DWI. We excluded 55 patients due to poor FU 
DWI quality, resulting in a total population of 252 patients. 
Baseline and follow-up characteristics for the subpopulation 
of this study and the overall HERMES patient group are 
shown in Table 1. The median age of the study population 
was 69 years, and a small majority was female. Most patients 
(81%) had a pre-stroke mRS of 0. The occlusion location 
Fig. 1  The division of brain regions according to high, moderate and low mRS relevance
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was most common within the M1 segment (72%) of the 
MCA, followed by the ICA-T (22%). Only a small number of 
patients had a M2 occlusion (6.1%). Within our study popu-
lation, 52% received endovascular treatment, from which 
46% also received IVT and 46% received IVT alone. The 
remaining 2% received neither IVT nor EVT and supportive 
care only. Favorable outcome at 90 days was reached in 53% 
of the study population. Figure 2 shows an example of the 
infarct segmentations on diffusion weighted MRI in areas 
with different mRS relevance. Figure 3 shows the infarct 
distribution for the study population for the axial, coronal 
and sagittal slice with the largest infarct probability. Lesions 
were most often present in the right lentiform nucleus.
Figure 4 shows box plots for the FIV for the low, moder-
ate, high mRS-relevant regions and total FIV in relation to 
mRS with corresponding standard deviations. The increase 
of FIV was associated with a higher risk of unfavorable out-
come for all the different regions. Moreover, the variance 
in infarct volume increased with worsening outcome, espe-
cially for high and low mRS-relevant regions.
Figure 5 shows the lesion volume for low, moderate and 
high mRS-relevant brain regions per patient. In patients with 
small total FIV, only high mRS-relevant brain regions were 
affected. With increasing total FIV, the lesions additionally 
occupied moderate mRS and subsequently low mRS-rele-
vant brain regions.
Table 1  Baseline and follow-up 
characteristics for our 
subpopulation and those of the 
HERMES dataset
Characteristic Volume analysis subgroup 
(n = 252) 
Mean ± SD (N) 
[Median] (IQR)
or % (n/N)
HERMES (n = 1764) 
Mean ± SD (N) 
[Median] (IQR)
or % (n/N)
Age (years) 66 ± 14 (251)
[69] (59, 76)
66 ± 14 (1761)
[68] (57, 76)
Male gender 49% (124/252) 53% (929/1762)
NIHSS at baseline 17 ± 4.9 (251)
[17] (13, 21)
17 ± 5.1 (1751)
[17] (13, 21)
Diabetes mellitus 16% (40/251) 16% (287/1756)
Atrial fibrillation 44% (77/177) 33% (447/1351)
Prior stroke 11% (27/252) 11% (188/1751)
Pre-stroke mRS
  0 81.4% (144/177) 83% (1057/1280)
  1 16% (28/177) 13% (162/1280)
  2 + 2.8% (5/177) 4.8% (61/1280)
Occlusion location
  ICA-T 22% (55/246) 20.2% (350/1731)
  M1 72% (176/246) 73.8% (1277/1731)
  M2 6.1% (15/246) 6.0% (104/1731)
  EVT allocation 52% (131/252) 49% (871/1764)
  tPA delivered 93% (233/252) 89% (1572/1764)
Treatment
  EVT + tPA 46% (117/252) 43% (763/1764)
  EVT only 5.6% (14/252) 6.1% (108/1764)
  tPA only 46% (116/252) 46% (809/1764)
Best medical management 2.0% (5/252) 4.8% (84/1764)
Onset to randomization (min) 195 ± 97.6 (252)
[180] (130.0,233.0)
202 ± 89 (1756)
[183] (140.0,245.0)
NIHSS at baseline
  0–4 0.4% (1/251) 0.4% (7/1751)
  5–15 42% (105/251) 37% (647/1751)
  16–20 32% (81/251) 37% (655/1751)
  21–42 26% (64/251) 25% (442/1751)
TICI 2b/3 (EVT-treated subjects only) 84% (97/115) 75% (550/729)
Favorable outcome at 90 days 53% (133/249) 47% (462/978)
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Results for the logistic regression models and ordinal 
logistic regression are presented in Table 2. For the univari-
able logistic models (models 1 to 4), all volume measures 
were significantly associated with favorable mRS. The odds 
ratio was highest for total FIV and lowest for low mRS-rele-
vant region FIV. For the multivariable model (model 5), only 
high mRS-relevant region FIV was significantly associated 
with favorable mRS. Similar results were obtained for the 
ordinal logistic regression model. Results after adjustments 
were comparable to the unadjusted analyses.
For the univariable logistic regression models, the AIC 
was lowest for the model that included high mRS-relevant 
FIV. The model including high mRS-relevant FIV was a 
better fit to the data than the multivariable model. For the 
ordinal logistic regression models, AIC was lowest for the 
model that included total FIV.
Only small differences were seen in the c-statistic for the 
different models. For the logistic model, the c-statistic was 
highest for the model that included high mRS-relevant FIV. 
However, according to DeLong’s test, there was no signifi-
cant difference between the c-statistic of the total FIV model 
(model 1) and the c-statistic for the high mRS-relevant FIV 
model (model 2). For the ordinal logistic regression models, 
the c-statistic was highest for both the model that included 
total FIV (model 6) and the high mRS-relevant FIV model 
(model 7).
Discussion 
For patients with AIS caused by an anterior large vessel 
occlusion, our results did not show significant differences 
between models, and therefore no differences in strength 
of associations between infarct volume and outcome were 
observed when lesion location was taken into account.
Lesions within low mRS-relevant regions were only pre-
sent in patients with higher total FIV. The results suggest 
that lesions progress from high mRS-relevant regions to less 
mRS-relevant regions when a stroke worsens. This agrees 
with the concept that leptomeningeal collaterals are relevant 
only to cortical MCA or ICA tissue and do not compensate 
for perfusion deficits in subcortical structures, such as the 
basal ganglia [22], and that ischemia progresses in case of 
late or inadequate reperfusion.
Our results did not correspond with the results pre-
sented by Ernst et al. [2], for which infarct lesion volume 
was quantified based on NCCT images. Their total FIV and 
high mRS-relevant FIV were overall larger compared to 
Fig. 2  An example of the infarct segmentations on diffusion weighted 
MRI in areas with different mRS relevance
Fig. 3  Infarct distribution shown for the axial (a), coronal (b) and sagittal (c) slice with the largest infarct probability present
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our study. Also, they showed a larger difference in volume 
between high mRS-relevant FIV and total FIV. The reason 
for discrepancy in our results was likely the difference in 
study populations. Ernst et al. only included patients from 
the MR CLEAN trial. The MR CLEAN trial included 
a relatively unselected group of patients with an anterior 
Fig. 4  Box plots showing the infarct volume distribution per mRS category for the low (a), moderate (b) and high (c) mRS-relevant infarct 
regions and the total infarct volume (d)
Fig. 5  Lesion volume distribu-
tion classified as low, moderate 
and high mRS relevant. Total 
lesion volume increases along 




circulation large vessel occlusion (ICA, middle cerebral 
artery M1 and M2 segments, anterior cerebral artery A1 and 
A2 segments) within 6 h after stroke onset and a National 
Institutes of Health Stroke Scale (NIHSS) score above 2. 
No other imaging selection criteria as ASPECTS, collat-
eral score or core and/or penumbra size on CTP were used. 
The inclusion criteria differed between trials and were more 
selective in some trials: patients were included if occlusions 
were present in only the intracranial carotid artery or mid-
dle cerebral artery (M1 segment) [13, 14, 23, 24], or only 
with more severe deficits [13], or with good collateral score 
[24], a core/penumbra mismatch[14] or smaller core [13] or 
a broader inclusion window [24].
Multiple studies have presented a voxel-based approach, 
studying the relation between specific anatomy and func-
tional outcome [3, 4, 25–27]. For example, Cheng et al. [3] 
used voxel-based lesion symptom mapping to study the rela-
tion of infarct lesion measured on fluid-attenuated inversion 
recovery imaging and functional outcome. They presented 
statistical maps which show the relation between the spa-
tial distribution of ischemic lesions and mRS at 1-month 
follow-up. Their results showed that the corona radiata, 
internal capsule and insula were of highest influence for 
mRS at 1 month. Laredo et al. [25] showed that large lesions 
strongly predict poor mRS, especially for insular lesions. 
Munsch et al. [4] studied the voxel-specific relation between 
infarct, measured on DWI, and mRS and cognitive function. 
Their results showed that infarct location is a significant pre-
dictor for cognitive function. However, they were not able 
to show a significant relation between location and dichoto-
mous mRS. Wu et al.[5] showed that the posterior limb of 
the internal capsule, corona radiata and especially the white 
matter tracts were associated with greater severity of AIS 
and poor long-term outcome.
In the study population, lesions were most present in the 
right lentiform nucleus, which consist of the putamen and 
globus pallidus. These regions are responsible for the sen-
sory and motor function, and learning processes. Russmann 
et al. [28] studied the effect of isolated lentiform nucleus 
infarcts. Infarcts in this region were related with sensory 
deficits, aphasia and hemineglect.
The current and previously presented moderate associa-
tion of infarct volume and functional outcome is possibly 
explained by Goyal et al. in their recent publication [29]. 
They state that the variability of tissue vulnerability causes 
heterogeneity in ischemic tissue. More specific, even though 
tissue appears infarcted on imaging, it is possible that this 
tissue is still (partially) salvageable and recovers over time. 
The heterogeneity of ischemia has previously been studied 
in small studies. Nagesh et al.[30] showed in 9 patients that 
within 10 h after stroke onset ischemic lesions consisted of 
multiple heterogenic zones of ADC values. Guadagno et al.
[31] showed, based on PET images of 5 patients, heterogene-
ity in blood flow and metabolism in regions that appeared 
Table 2  Associations between 
the total follow-up infarct lesion 
volume and the follow-up 
infarct lesion volume divided in 
high, moderate and low mRS-
relevant regions and favorable 
mRS at 90 days
†Adjusted for age, sex, diabetes mellitus, atrial fibrillation, previous stroke or pre-stroke mRS > 0, treat-





Logistic regression (favorable outcome, mRS ≤ 2)
  Univariable
    Model 1 Total FIV 0.83 (0.77, 0.89) 300 0.75 0.78 (0.70, 0.86)
    Model 2 High mRS-relevant FIV 0.62 (0.53, 0.74) 295 0.76 0.53 (0.42, 0.67)
    Model 3 Moderate mRS-relevant FIV 0.72 (0.62, 0.83) 322 0.74 0.66 (0.54, 0.81)
    Model 4 Low mRS-relevant FIV 0.50 (0.38, 0.66) 309 0.70 0.45 (0.31, 0.65)
  Multivariable
    Model 5 High mRS-relevant FIV 0.67 (0.53, 0.84) 298 0.76 0.56 (0.41, 0.76)
Moderate mRS-relevant FIV 1.00 (0.80, 1.25) 0.87 (0.66, 1.16)
Low mRS-relevant FIV 0.86 (0.54, 1.35) 1.12 (0.65, 1.95)
Ordinal logistic regression (shift towards better outcome)
  Univariable
    Model 6 Total FIV 0.84 (0.81, 0.88) 830 0.72 0.83 (0.79, 0.87)
    Model 7 High mRS-relevant FIV 0.70 (0.64, 0.77) 837 0.72 0.67 (0.60, 0.78)
    Model 8 Moderate mRS-relevant FIV 0.72 (0.65, 0.80) 859 0.71 0.69 (0.61, 0.78)
    Model 9 Low mRS-relevant FIV 0.52 (0.44, 0.62) 841 0.69 0.51 (0.42, 0.62)
  Multivariable
    Model 10 High mRS-relevant FIV 0.79 (0.69, 0.91) 832 0.72 0.76 (0.65, 0.89)
Moderate mRS-relevant FIV 0.89 (0.77, 1.04) 0.83 (0.67, 1.37)
Low mRS-relevant FIV 0.86 (0.62, 1.21) 0.96 (0.67, 1.37)
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hyperintense on DWI. Considering these insights, previously 
and current presented infarct volumes probably do not cor-
rectly represent true infarct.
This study suffers from some limitations. First, even 
though the HERMES collaboration combined multiple 
large randomized controlled trials with a heterogeneous 
population, our substudy population was relatively small 
and consists of highly selected patients. FU MRI is often 
not included within standard imaging protocol for FU stroke 
imaging. As a result, our study population only contained 
patients from the HERMES centers that included 24-h FU 
MRI within their study protocol. Moreover, the HERMES 
trials included only patients without prior disability, with 
proximal anterior circulation large vessel occlusions who 
were eligible for EVT. Since all patients had anterior circula-
tion large vessel occlusions, the spectrum of patient deficits 
was more similar than occurs in an unselected stroke patient 
population that would include a majority with medium 
and small vessel occlusions in more locations, including 
patients with posterior circulation occlusions. Strategic 
location effects are likely to be more marked when over-
all lesion volumes are smaller and more varied. Also, our 
study population does not represent minor or severe cases 
of stroke. It is expected that patients with infarcts that affect 
low-mRS relevant regions experience fewer symptoms and 
are therefore less likely to present acutely in time window 
for acute interventions (IVT or EVT). Patients who did not 
meet the inclusion criteria for the trials due to contraindica-
tions, such as late presentation or high NIHSS score, were 
also not included. In addition, the majority of trials selected 
patients according to imaging characteristics such as the 
extent of changes on non-contrast CT or MRI, perfusion 
characteristics or collateral vessel quality. It is also plausible 
that MRI scans were only acquired for patients that had a 
better early outcome and were therefore able to tolerate MRI 
acquisition. Since patients with clinically or radiologically 
severe presentations are expected to have worse outcome 
than those included in the HERMES trials, future studies 
should assess the influence of lesion location and outcome 
for this population. Also, our study did not take hemi-
spheric dominance into account. Finally, in this study, the 
mRS score was used for defining functional outcome. This 
score is a common endpoint in acute ischemic stroke trials 
and measures the degree of dependence in daily activities. 
The score is mainly focused on motor function (particularly 
walking) and is less sensitive for the evaluation of complex 
or cognitive functions such as memory or emotional pro-
cessing [24]. Lack of association of radiologically defined 
tissue volumes weighted by relevance to the mRS therefore 
is strongly biased towards motor function and does not cover 
regions such as the cingulate gyrus (which is involved in 
emotional processing) or parahippocampal gyrus (which is 
involved in memory processing). In addition, simplifying 
the mRS outcome into an arbitrary dichotomy of “good” and 
“poor” may obscure structure–function relationships. Future 
studies should focus on the relation between the NIHSS in 
combination of the Montreal cognitive assessment score and 
infarct location. We expect a stronger relation between neu-
rological impairment found with these scores and specific 
brain regions.
According to our results, information on the specific post-
treatment infarct location depicted on DWI does not con-
tribute to better estimation of treatment outcome. Probably, 
this is because the high mRS-relevant regions are always 
included within the infarct.
Conclusion
Our results confirm the association between FIV as depicted 
on follow-up DWI and favorable functional outcome. We 
have shown that for patients with an infarct resulting from an 
ICA/MCA occlusion, the association between FIV quanti-
fied on follow-up DWI and functional outcome according to 
the modified Rankin scale (mRS) is not strengthened when 
lesion location is taken into account.
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